NCT05104489View on ClinicalTrials.gov

Dose-finding Study for AdimrSC-2f Vaccine

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

January 3, 2022

Primary Completion Date

December 29, 2022

Study Completion Date

July 26, 2023

Conditions
COVID-19
Interventions
BIOLOGICAL

AdimrSC-2f

IM injection

Trial Locations (1)

55281

University Gadjah Mada Academic Hospital, Yogyakarta

Sponsors
All Listed Sponsors
lead

Adimmune Corporation

INDUSTRY

NCT05104489 - Dose-finding Study for AdimrSC-2f Vaccine | Biotech Hunter | Biotech Hunter